These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 2051455)
21. Hepatic acetylator phenotype in bladder cancer patients. Ladero JM; Kwok CK; Jara C; Fernandez L; Silmi AM; Tapia D; Uson AC Ann Clin Res; 1985; 17(3):96-9. PubMed ID: 4051447 [TBL] [Abstract][Full Text] [Related]
22. N-acetylation polymorphism and diabetes mellitus among Saudi Arabians. el-Yazigi A; Johansen K; Raines DA; Dossing M J Clin Pharmacol; 1992 Oct; 32(10):905-10. PubMed ID: 1447397 [TBL] [Abstract][Full Text] [Related]
23. Relationship between acetylator phenotype and intensity of the hypoglycaemic effect of a suplhonamide preparation in children with insulin-dependent diabetes. Hadasová E; Brysová V; Utĕsený J; Macků M Bratisl Lek Listy; 1991 Dec; 92(12):609-14. PubMed ID: 1806177 [TBL] [Abstract][Full Text] [Related]
25. Acetylator status and its relationship to breast cancer and other diseases of the breast. Philip PA; Rogers HJ; Millis RR; Rubens RD; Cartwright RA Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1701-6. PubMed ID: 3428335 [TBL] [Abstract][Full Text] [Related]
30. N-acetylation pharmacogenetics. Michaelis-Menten constants for arylamine drugs as predictors of their N-acetylation rates in vivo. Andres HH; Weber WW Drug Metab Dispos; 1986; 14(4):382-5. PubMed ID: 2873982 [TBL] [Abstract][Full Text] [Related]
31. The GSTM1 genetic polymorphism in healthy Saudi Arabians and Filipinos, and Saudi Arabians with coronary atherosclerosis. Evans DA; Seidegård J; Narayanan N Pharmacogenetics; 1996 Aug; 6(4):365-7. PubMed ID: 8873224 [No Abstract] [Full Text] [Related]
32. N-acetylation and oxidative capacity in aged volunteers determined with sulfamethazine and antipyrine. Siegmund W; Franke G; Wulkow R; Hanke W; Thonack R Int J Clin Pharmacol Ther Toxicol; 1991 Dec; 29(12):469-73. PubMed ID: 1813431 [TBL] [Abstract][Full Text] [Related]
34. Drug acetylator phenotypes in newborn infants. Szórády I; Sánta A; Veress I Biol Res Pregnancy Perinatol; 1987; 8(1 1ST Half):23-5. PubMed ID: 3580445 [TBL] [Abstract][Full Text] [Related]
35. The association of the slow acetylator phenotype with bladder cancer. Evans DA; Eze LC; Whibley EJ J Med Genet; 1983 Oct; 20(5):330-3. PubMed ID: 6644762 [TBL] [Abstract][Full Text] [Related]
36. Effect of acetaminophen on sulfamethazine acetylation in male volunteers. Tahir IM; Iqbal T; Saleem S; Mehboob H; Akhter N; Riaz M Int J Immunopathol Pharmacol; 2016 Mar; 29(1):17-22. PubMed ID: 26519524 [TBL] [Abstract][Full Text] [Related]
37. [Distribution of acetylator phenotypes in the Moscow population]. Lil'in ET; Korsunskaia MP; Meksin VA; Tarlycheva LV; Shapiro EF Genetika; 1983 Aug; 19(8):1378-80. PubMed ID: 6685091 [TBL] [Abstract][Full Text] [Related]
38. Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Frederickson SM; Messing EM; Reznikoff CA; Swaminathan S Cancer Epidemiol Biomarkers Prev; 1994; 3(1):25-32. PubMed ID: 8118381 [TBL] [Abstract][Full Text] [Related]
39. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe. William BM; Abdel-tawab AM; Hassan EA; Mohamed OF Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499 [TBL] [Abstract][Full Text] [Related]
40. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Hein DW; Doll MA; Gray K; Rustan TD; Ferguson RJ Cancer Res; 1993 Feb; 53(3):509-14. PubMed ID: 8425184 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]